GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (FRA:TG40) » Definitions » 6-1 Month Momentum %

Oxurion NV (FRA:TG40) 6-1 Month Momentum % : -72.35% (As of Dec. 14, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Oxurion NV 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-12-14), Oxurion NV's 6-1 Month Momentum % is -72.35%.

The industry rank for Oxurion NV's 6-1 Month Momentum % or its related term are showing as below:

FRA:TG40's 6-1 Month Momentum % is ranked worse than
94.22% of 1471 companies
in the Biotechnology industry
Industry Median: -8.83 vs FRA:TG40: -72.35

Competitive Comparison of Oxurion NV's 6-1 Month Momentum %

For the Biotechnology subindustry, Oxurion NV's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxurion NV's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxurion NV's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Oxurion NV's 6-1 Month Momentum % falls into.



Oxurion NV  (FRA:TG40) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxurion NV  (FRA:TG40) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Oxurion NV 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Oxurion NV's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxurion NV Business Description

Traded in Other Exchanges
Address
Gaston Geenslaan 1, Leuven, BEL, B-3001
Oxurion NV is a clinical-stage biopharmaceutical company developing next-generation standard-of-care ophthalmic therapies, which are designed to improve and preserve vision in patients with retinal disorders including Geographic Atrophy (GA). The Group's research and development facilities are located in Belgium. The Company is engaged in the development of drugs to treat blindness diseases.

Oxurion NV Headlines

No Headlines